View Clinical Trial (Medical Research Study)

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis - NCT00876447-(Clinical Trial 282468)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Middlebury
State:  
CT
Zip Code:
Conditions: Overactive Bladder
Purpose: The purpose of this study is to assess the long-term safety and effectiveness of botulinum toxin type A on patients with overactive bladder as a result of spinal cord injury or multiple sclerosis. This is a follow-up study to two ongoing Allergan sponsored studies (NCT00311376 and NCT00461292).
Study summary:
Criteria: Inclusion Criteria: - Patient has participated in study 191622-515 or 191622-516 and the following criteria fulfilled: - Patient completed at least 52 weeks in the preceding study. - No longer than 6 months has elapsed since completion of the preceding study - Patient has not received any prohibited medications during any intervening period between the preceding study and this long-term study. Exclusion Criteria: - History or evidence of pelvic or urologic abnormality. - Previous or current diagnosis of bladder or prostate cancer.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: February 17, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.